Omega Pharma Acquires Six Glaxo OTC Brands, But Alli Lingers
This article was originally published in The Tan Sheet
Executive Summary
Omega Pharma will pay $619 million for GSK’s Lactacyd feminine wash products, Abtei supplements, Solpadeine analgesics, Zantac antacid, Nytol sleep aids and the allergy drug Beconase. The deal is part of Glaxo’s plan to simplify its consumer business by selling 19 OTC brands.
You may also be interested in...
Perrigo Fills “Moat” To Protect Growth With Gummy Vitamins, European Flavor
The private labeler announces Ferrara Candy will manufacture store brand gummy vitamins and supplements that Perrigo will provide to U.S. retailers. The firm expects by the end of the current quarter to close its acquisition of Belgian OTC and nutritional product manufacturer Omega Pharma.
Perrigo Fills “Moat” To Protect Growth With Gummy Vitamins, European Flavor
The private labeler announces Ferrara Candy will manufacture store brand gummy vitamins and supplements that Perrigo will provide to U.S. retailers. The firm expects by the end of the current quarter to close its acquisition of Belgian OTC and nutritional product manufacturer Omega Pharma.
Perrigo Fills “Moat” To Protect Growth With Gummy Vitamins, European Flavor
The private labeler announces Ferrara Candy will manufacture store brand gummy vitamins and supplements that Perrigo will provide to U.S. retailers. The firm expects by the end of the current quarter to close its acquisition of Belgian OTC and nutritional product manufacturer Omega Pharma.